1-9 of 9
Dag Josefsen, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A WT-1 and PRAME "Fast-DC" Immunotherapy As a Potential Post-Remission Strategy for AML

Yngvar Floisand, MD PhD, Iris Bigalke, MD, Dag Josefsen, MD PhD, Silke Raffegerst, PhD, Frauke Schnorfeil, PhD, Richard Addo, MD PhD, Dolores J. Schendel, PhD, Kai Pinkernell, MDMBA, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11.
https://doi.org/10.1182/blood-2020-139255
Published: 2020
Journal Articles

Immune Monitoring of Vaccine Quality and Persistence of Specific T Cell Responses in Five AML Patients Receiving Extended Dendritic Cell Vaccination Under Compassionate Use

Iris Bigalke, MD, Judith Eckl, PhD, Guri Solum, MSc, Kirsti Hønnåshagen, Msc, Lisbeth Skoge, MSc, Yngvar Fløisand, MD PhD, Dag Josefsen, MD PhD, Stein Sæbøe-Larssen, PhD, Christiane Geiger, PhD, Dolores Schendel, PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2718.
https://doi.org/10.1182/blood-2018-99-114557
Published: 2018
Journal Articles

Poor Mobilizing Lymphoma Patients Rescued By Addition of Plerixafor during Stem Cell Mobilization Have Equal Survival As Good Mobilizers When Given High Dose Therapy with Autologous Stem Cell Support

Dag Josefsen, MD PhD, Yngvar Fløisand, MD PhD, Harald Holte, Jr., MD PhD, Gunnar Kvalheim, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5826.
https://doi.org/10.1182/blood.V128.22.5826.5826
Published: 2016
Journal Articles

The Use Of Plerixafor In Hard-To-Mobilize Lymphoma and Multiple Myeloma Patients Not Only Provide Sufficient Numbers Of Pbpcs To Proceed To High Dose Therapy, But Also Have a Positive Impact On Survival

Dag Josefsen, MD, PhD, Geir Hetland, MD, PhD, Yngvar Fløisand, MD, Ph.D, Harald Holte, MD, PhD, Gunnar Kvalheim, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5517.
https://doi.org/10.1182/blood.V122.21.5517.5517
Published: 2013
Journal Articles

Diverse Genetic Lesions In Myelodysplastic Syndromes Originate Exclusively In Rare MDS Stem Cells

Petter Woll, PhD, Una Kjällquist, Onima Chowdhury, M.D., Rikard Erlandsson, Ph.D., Helen Doolittle, M.D., Mtakai Ngara, Kristina Anderson, MD, Eleni Giannoulatou, Stephen Taylor, Qiaolin Deng, Adam J. Mead, M.D., Ph.D., Christian Scharenberg, MD, Teresa Mortera-Blanco, PhD, Iain C Macaulay, Ph.D., sally-Ann Clark, Dag Josefsen, MD, PhD, Gunnar Kvalheim, MD, PhD, Gudrun Göhring, MD, Brigitte Schlegelberger, MD, PhD, Magnus Tobiasson, MD, Mette S. Holm, MD, PhD, Peter Hokland, MD, DMSC, Pierre Fenaux, Claus Nerlov, PhD, Ingunn Dybedal, MD, PhD, Lars Nilsson, MD, PhD, Rickard Sandberg, PhD, Eva Hellström-Lindberg, MD, PhD, Sten Linnarsson, PhD, Sten Eirik W Jacobsen, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4195.
https://doi.org/10.1182/blood.V122.21.4195.4195
Published: 2013
Journal Articles

Favorable Therapeutic Responses in Newly Diagnosed CML-CP Patients Induced by Dasatinib Are Reflected At the CD34+CD38+ Progenitor Cell but Not At the CD34+CD38− Stem Cell Level: Results From Randomized NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Hans Ehrencrona, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn Gjertsen, MD, PhD, Randi Hovland, PhD, Sari E Jalkanen, MSc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Msc, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Mosfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 784.
https://doi.org/10.1182/blood.V118.21.784.784
Published: 2011
Journal Articles

The Proportion of Ph+ CD34 + CD38 neg Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Satu Mustjoki, MD, PhD, Johan Richter, MD, PhD, Gisela Barbany, MD, PhD, Ingunn Dybedal, MD, PhD, Thoas Fioretos, MD, PhD, Tobias Gedde-Dahl, MD, PhD, Bjorn T. Gjertsen, MD, PhD, Randi Hovland, PhD, Sari Jalkanen, Msc, Dag Josefsen, MD, PhD, Perttu Koskenvesa, MD, Carin Lassen, Kirsi Latvala, Waleed Majeed, MD, Claes Malm, MD, Berit Markevärn, MD, Ali Moshfegh, PhD, Lotta Ohm, MD, Tor Olofsson, MD, PhD, Ulla Olsson-Strömberg, MD, PhD, Katrin Rapakko, PhD, Kari Remes, MD, PhD, Jesper Stentoft, MD, PhD, Leif Stenke, MD, PhD, Merja Suominen, MD, Sara Thunberg, MD, PhD, Ole Weiss Bjerrum, MD, PhD, Bengt Simonsson, MD, PhD, Kimmo Porkka, MD, PhD, Henrik Hjorth-Hansen, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 667.
https://doi.org/10.1182/blood.V116.21.667.667
Published: 2010
Journal Articles

Human Bone Marrow Mononuclear Cells, CD34+ Cells and CD133+ Cells Do Not Form Vascular Structures in Vivo

Dag Josefsen, MD, PhD, Axel Kuchler, Mengyu Wang, Guttorm Haraldsen, Gunnar Kvalheim
Journal: Blood
Blood (2008) 112 (11): 5453.
https://doi.org/10.1182/blood.V112.11.5453.5453
Published: 2008
Journal Articles

Characterisation of Side Population (SP) Cells Obtained from Different Hematopoietic Progenitor/Stem Cell Compartments in Human Bone Marrow and Peripheral Blood.

Dag Josefsen, MD, PhD, Lise Forfang, Marianne Dyrhaug, Gunnar Kvalheim, MD, Ph.D
Journal: Blood
Blood (2006) 108 (11): 4170.
https://doi.org/10.1182/blood.V108.11.4170.4170
Published: 2006